The rise of Candida auris: from unique traits to co-infection potential
Cancer immunotherapy, which use the own immune system to attack tumors, are increasingly popular treatments. But, due to the tumor immunosuppressive microenvironment, the antigen presentation in the tumor is limited. Recently, a growing number of people use bacteria to stimulate the body’s immunity...
Saved in:
| Main Authors: | Haiheng Xu, Yiqiao Hu, Jinhui Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shared Science Publishers OG
2022-08-01
|
| Series: | Microbial Cell |
| Subjects: | |
| Online Access: | http://microbialcell.com/researcharticles/2022a-xu-microbial-cell/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategies for in situ reprogramming of tumor cells into antigen-presenting cells
by: LIN Yongfang, et al.
Published: (2024-11-01) -
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01) -
A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines
by: Linghong Huang, et al.
Published: (2025-04-01) -
Harnessing Dendritic Cell Function in Hepatocellular Carcinoma: Advances in Immunotherapy and Therapeutic Strategies
by: Shiding Ying, et al.
Published: (2025-05-01) -
B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
by: Ichwaku Rastogi, et al.
Published: (2023-12-01)